ClinicalTrials.govpublic full text
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
endometrioid cancer, mucinous ovarian cancer, high grade serous ovarian cancer, cervical cancer, solid tumor, avutometinib, defactinib, vs-6766, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 860928
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.